Nevro wants to be more than just a spinal cord stimulation (SCS) company.
Since its founding about 17 years ago, the Redwood City, CA-based company has focused on developing and marketing its high-frequency 10 kHz (HFX) implantable SCS devices to treat chronic pain,...
Nevro Acqures Vyrsa For Up To $75m
On 30 November, Nevro announced that it has signed and closed a deal to pay $40m at closing to acquire Pennsylvania-based Vyrsa.
Nevro also...